NCT01160965

Brief Summary

The aim of this trial is to compare the local anaesthetic ropivacaine to local anaesthetic levobupivacaine in converting the standard patient controlled labour epidural to provide anaesthesia for an emergency Caesarean section. This is a technique commonly known as an epidural top-up. The investigators set out to disprove the hypothesis that there is no difference between the 2 local anaesthetics in the time of onset and number of times epidural top-up needs supplementing during surgery.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2012

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2010

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 13, 2010

Completed
2.1 years until next milestone

Study Start

First participant enrolled

August 1, 2012

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

December 29, 2011

Status Verified

December 1, 2011

Enrollment Period

1 year

First QC Date

July 7, 2010

Last Update Submit

December 28, 2011

Conditions

Keywords

epidural top-upemergency Caesarean section

Outcome Measures

Primary Outcomes (1)

  • Supplementation Rate

    The number of times the epidural anaesthetic requires intra-operative supplementation with more study solution or another drug for pain.

    During operation (approximately 1 hour )

Secondary Outcomes (9)

  • Pre-operative supplementation

    10-45mins (top-up to start of surgery)

  • Pain

    During operation (approximately 1 hour)

  • Conversion Rate

    At any point between epidural top-up and end of operation (approximately 90mins from epidural top-up)

  • Side effects

    At any point between top-up of epidural and end of operation (approximately 90mins from epidural top-up)

  • Blood pressure supplementation rate

    At any point from top-up of epidural to end of operation (approximately 90mins from epidural top-up)

  • +4 more secondary outcomes

Study Arms (2)

0.5% levobupivacaine

ACTIVE COMPARATOR

Participants given 15mls of 0.5% levobupivacaine as the solution for their epidural top-up

Drug: 0.5% levobupivacaine

0.75% Rpoivacaine

ACTIVE COMPARATOR

Participants given 15mls of 0.75% ropivacaine as the solution for their epidural top-up.

Drug: 0.75% Ropivacaine

Interventions

15mls of a 5mg/ml solution of the local anaesthetic levobupivacaine given via the epidural catheter.

Also known as: 0.5% Chirocaine
0.5% levobupivacaine

15mls of a 7.5mg/ml solution of the local anaesthetic ropivacaine given via the epidural catheter.

0.75% Rpoivacaine

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Any subject requiring a grade 2 or 3 EmCS on the Hospital Birth Centre, St Thomas' who has:
  • Labour analgesia provided by the standard patient controlled epidural (solution containing 0.1% levobupivacaine and 2mcg/ml fentanyl). That is providing analgesia via the patient controlled epidural analgesia infusion pump without the need for multiple extra boluses of epidural local anaesthetic and or opiates from the anaesthetist on the labour ward..
  • Singleton pregnancy.
  • Established labour, determined by the midwife responsible for the patient (usually by vaginal examination of the cervix).
  • Gestation \>36 weeks
  • No complex past medical history according to the judgement of the investigator
  • \> 18 years of age
  • EmCS starts between the hours 0800 and 1800.
  • The ability to understand the patient information sheet and willing to provide informed consent.
  • Had a minimal total dose of 50mcg of fentanyl since insertion of epidural

You may not qualify if:

  • Pre-eclampsia / Eclampsia
  • Antepartum haemorrhage
  • Any congenital, structural or ischaemic heart disease.
  • Category 1 EmCS.
  • Participation in another therapeutic study in the last 12 weeks. -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Thomas' Hospital

London, SE1 7EH, United Kingdom

Location

Related Publications (2)

  • Sanders RD, Mallory S, Lucas DN, Chan T, Yeo S, Yentis SM. Extending low-dose epidural analgesia for emergency Caesarean section using ropivacaine 0.75%. Anaesthesia. 2004 Oct;59(10):988-92. doi: 10.1111/j.1365-2044.2004.03753.x.

  • Sng BL, Pay LL, Sia AT. Comparison of 2% lignocaine with adrenaline and fentanyl, 0.75% ropivacaine and 0.5% levobupivacaine for extension of epidural analgesia for urgent caesarean section after low dose epidural infusion during labour. Anaesth Intensive Care. 2008 Sep;36(5):659-64. doi: 10.1177/0310057X0803600505.

MeSH Terms

Interventions

LevobupivacaineRopivacaine

Intervention Hierarchy (Ancestors)

BupivacaineAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • geraldine e o'sullivan, MBBCh

    Guy's and St Thomas' NHS Foundation Trust

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 7, 2010

First Posted

July 13, 2010

Study Start

August 1, 2012

Primary Completion

August 1, 2013

Study Completion

August 1, 2014

Last Updated

December 29, 2011

Record last verified: 2011-12

Locations